A team of scientists and doctors from the KK Women's and Children's Hospital (KKH), Yong Loo Lin School of Medicine, National University of Singapore (NUS Medicine) and the Institute for Health Innovation and Technology has ...
Oct 5, 2022
0
39
Children who suffer a relapse of the aggressive cancer known as neuroblastoma have small chances of survival. However, a group including researchers at Karolinska Institutet in Sweden have now shown that DHODH blockers, which ...
Aug 22, 2022
0
27
Neuroblastoma, a childhood cancer that develops from neural cells on the adrenal glands, accounts for 15% of childhood cancer deaths. Almost half of children with high-risk neuroblastoma harbor extra copies of the gene MYCN ...
Aug 17, 2022
0
96
In a study recently published in Cancer Research, a team of researchers led by C. Patrick Reynolds, M.D., Ph.D., director for the Texas Tech University Health Sciences Center (TTUHSC) School of Medicine Cancer Center, sought ...
Aug 10, 2022
0
40
New research from VCU Massey Cancer Center published Thursday in Cell Reports has demonstrated that a novel targeted therapy could be an effective treatment option for a deadly pediatric cancer known as neuroblastoma.
Jul 28, 2022
0
27
In a new study, researchers at Karolinska Institutet show that the activation of specific cell surface proteins—cortisol, estrogen and vitamin A—in mice with human neuroblastoma cells results in the neuronal differentiation ...
Jul 25, 2022
0
22
Approximately half of children with neuroblastoma—a childhood cancer that develops from immature nerve cells—have a form that indicates a high likelihood of recurrence. New findings published by Wiley online in Cancer ...
Jun 6, 2022
0
17
Every year, approximately one in 100,000 children develops a new neuroblastoma, often in the first year of life. This makes neuroblastomas a relatively common group of tumors in children. They form in immature nerve tissue ...
Apr 28, 2022
0
16
A new study by researchers at Children's Hospital of Philadelphia (CHOP) shows that linking a tumor-killing prodrug to a macromolecular carrier of the Poloxamer family improves retention of the drug in treatment-resistant ...
Mar 14, 2022
0
276
A Ludwig Cancer Research study has identified in neuroblastoma tumors a potential vulnerability that might be exploited to improve treatment of the aggressive childhood cancer, which accounts for roughly 15% of all deaths ...
Feb 7, 2022
0
60
